Avantor (NYSE:AVTR – Get Free Report) will post its quarterly earnings results before the market opens on Friday, October 25th. Analysts expect Avantor to post earnings of $0.25 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Avantor Stock Performance
AVTR stock opened at $23.72 on Thursday. The business’s 50-day moving average price is $25.59 and its two-hundred day moving average price is $24.30. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The firm has a market cap of $16.11 billion, a PE ratio of 60.82, a P/E/G ratio of 2.93 and a beta of 1.33. Avantor has a 1-year low of $16.63 and a 1-year high of $28.00.
Insider Buying and Selling at Avantor
Wall Street Analyst Weigh In
Several research firms have issued reports on AVTR. Evercore ISI dropped their price target on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Morgan Stanley lifted their price target on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Stifel Nicolaus lifted their price target on Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Barclays lifted their price target on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, TD Cowen lifted their price target on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $28.00.
Read Our Latest Report on Avantor
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- How to Invest in Small Cap StocksĀ
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How Investors Can Find the Best Cheap Dividend Stocks
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How Can Investors Benefit From After-Hours Trading
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.